Feedback / Questions
vimirogant (VTP-43742) - AbbVie
VTP-43742: Launch for psoriasis in 2022
(Allergan)
-
Feb 16, 2018 -
Annual Report 2017
Launch
•
Psoriasis
https://www.allergan.com/investors/financial-information/sec-filings
Feb 16, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious